Egypt has launched a high-priority government initiative to transform its pharmaceutical and apparel sectors into global export powerhouses.
On March 2, 2026, ministers of Industry, Investment, and Labor convened a series of strategic meetings to roll out an executive roadmap designed to localize manufacturing, deepen industrial integration, and aggressively expand Egypt’s market share across Africa and beyond.
In the pharmaceutical sector, Minister of Industry Khaled Hashem emphasized that connectivity between researchers and manufacturers is now a national priority. The government is pushing for the adoption of artificial intelligence and advanced biotechnology to slash drug development costs and reduce the nation’s reliance on imported raw materials. This strategy is backed by a major expansion of the “concessional financing initiative,” which has raised credit limits to 150 million EGP for related industrial parties. By providing subsidized interest rates—often below 15%—the state aims to incentivize companies to localize production and secure the nation’s drug safety.
Simultaneously, the Ministry of Investment and Foreign Trade is targeting a record $4.4 billion in garment exports for 2026, a 22% increase driven by a surge in Turkish and Chinese investments. To sustain this momentum, the government is focusing on modernizing the entire textile value chain, from spinning to ready-to-wear finishing. By leveraging its strategic proximity to Europe and its robust network of trade agreements, Egypt aims to position itself as the primary alternative to traditional Asian manufacturing hubs.
This coordinated effort is part of a broader vision to quadruple textile exports by 2030 and reach $3 billion in annual medical exports. With a focus on high-value manufacturing and professionalizing the workforce, Cairo is betting that deep institutional coordination and performance-linked incentives will cement its role as a regional industrial hub and a key player in the global supply chain.
Source: https://apanews.net/